Skip to main content
SpringerLink
Log in

Options for Amyloid Typing in Renal Pathology: The Advantages of Frozen Section Immunofluorescence and a Summary of General Recommendations Regarding Immunohistochemistry Methods

  • Chapter
Amyloid and Related Disorders

Part of the book series: Current Clinical Pathology ((CCPATH))

Abstract

Amyloid typing by antibody-based methods continues to play a major role in clinical practice. However, it must be stressed that the immunohistochemistry of amyloid differs markedly from that used routinely in other areas of general surgical pathology. In this chapter, another specialized form of immunohistochemistry, namely immunofluorescence performed on frozen sections, will be discussed. This technique is routinely used by renal pathology laboratories in North America and many other parts of the world and contributes significantly to amyloid typing in clinical practice. The advantages of amyloid typing on frozen sections, as typically performed in renal pathology, over immunohistochemistry performed on paraffin sections, as typically used in general surgical pathology, are discussed. The applicability of immunofluorescence on frozen tissue to non-renal pathology specimens is also reviewed. Finally, specific issues related to amyloid immunohistochemistry versus general immunohistochemistry and other methods are discussed. General recommendations based on a consensus conference held during the XIIth International Symposium on Amyloidosis regarding amyloid typing in surgical pathology are also summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Picken MM, Westermark P. Amyloid detection and typing: summary of current practice and recommendations of the consensus group. Amyloid. 2011;18 Suppl 1:48–50.

    Article  PubMed  Google Scholar 

  2. Picken MM. Current practice in amyloid detection and typing among renal pathologists. Amyloid. 2011;18 Suppl 1:73–5.

    Article  PubMed  Google Scholar 

  3. Leung N, Nasr SH, Sethi S. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood. 2012;120(16):3206–16.

    Article  CAS  PubMed  Google Scholar 

  4. Picken MM. Amyloid typing in surgical pathology—experience of a single institution. In: Skinner M, Berk JL, Connors LH, Seldin DC, editors. XIth International Symposium on Amyloidosis; Boca Raton, FL: CRC Press; 2007. p. 289–91.

    Google Scholar 

  5. Schönland SO1, Hegenbart U, Bochtler T, Mangatter A, Hansberg M, Ho AD, Lohse P, Röcken C. Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood. 2012;119(2):488–93. doi:10.1182/blood-2011-06-358507. Epub 2011 Nov 21.

    Article  PubMed  Google Scholar 

  6. Linke RP. On typing amyloidosis using immunohistochemistry. Detailed illustrations, review and a note on mass spectrometry. Prog Histochem Cytochem. 2012;47(2):61–132. Epub 2012 Jul 20.

    Article  PubMed  Google Scholar 

  7. Herrera GA, Picken MM. Renal diseases associated with plasma cell dyscrasias, amyloidoses, waldenstrom macroglobulinemia and cryoglobuminemic nephropathies. In: Jennette JC, Olson JL, Silva FG, Agati VD’, editors. Heptinstall’s pathology of the kidney. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. p. 951–1014.

    Google Scholar 

  8. Walker PD, Cavallo T, Bonsib SM. Ad hoc committee on renal biopsy guidelines of the renal pathology society. Practice guidelines for the renal biopsy. Mod Pathol. 2004;17(12):1555–63.

    Article  PubMed  Google Scholar 

  9. Gallo G, Picken MM, Buxbaum J, Frangione B. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component. Mod Pathol. 1988;1:453–6.

    CAS  PubMed  Google Scholar 

  10. Fermand JP, Bridoux F, Kyle RA, Kastritis E, Weiss BM, Cook MA, Drayson MT, Dispenzieri A, Leung N. International kidney and monoclonal gammopathy research group. How I treat monoclonal gammopathy of renal significance (MGRS). Blood. 2013;122(22):3583–90. Epub 2013 Oct 9.

    Article  CAS  PubMed  Google Scholar 

  11. Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens. 2007;16(3):196–203.

    Article  PubMed  Google Scholar 

  12. von Hutten H, Mihatsch M, Lobeck H, Rudolph B, Eriksson M, Röcken C. Prevalence and origin of amyloid in kidney biopsies. Am J Surg Pathol. 2009;33(8):1198–205.

    Article  Google Scholar 

  13. Picken MM. Amyloidosis-where are we now and where are we heading? Arch Pathol Lab Med. 2010;134(4):545–51.

    PubMed  Google Scholar 

  14. Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, Herrera Hernandez L, Vrana JA, Theis JD, Quint PS, Dogan A, Nasr SH. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol. 2013;8:1515–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Larsen CP, Walker PD, Weiss DT, Solomon A. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int. 2010;77(9):816–9.

    Article  CAS  PubMed  Google Scholar 

  16. Said SM, Sethi S, Valeri AM, Chang A, Nast CC, Krahl L, Molloy P, Barry M, Fidler ME, Cornell LD, Leung N, Vrana JA, Theis JD, Dogan A, Nasr SH. Renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int. 2014;86:370–7. Published online 22 Jan 2014.

    Article  CAS  PubMed  Google Scholar 

  17. Larsen CP, Kossmann RJ, Beggs ML, Solomon A, Walker PD. Renal leukocyte chemotactic factor 2 amyloidosis (ALECT2): a case series detailing clinical, morphologic, and genetic features. Kidney Int. 2014;86:378–82. Published online 12 Feb 2014.

    Article  CAS  PubMed  Google Scholar 

  18. Picken MM. Alect2 amyloidosis: primum non nocere (first, do no harm). Kidney Int. 2014;86(2):229–32.

    Article  CAS  PubMed  Google Scholar 

  19. Mereuta OM, Theis JD, Vrana JA, Law ME, Grogg KL, Dasari S, Chandan VS, Wu TT, Jimenez-Zepeda VH, Fonseca R, Dispenzieri A, Kurtin PJ, Dogan A. Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States. Blood. 2014;123(10):1479–82.

    Article  CAS  PubMed  Google Scholar 

  20. Collins AB, Smith RN, Stone JR. Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence. Cardiovasc Pathol. 2009;18(4):205–16.

    Article  CAS  PubMed  Google Scholar 

  21. Picken MM. Modern approaches to the treatment of amyloidosis—the critical importance of early detection in surgical pathology. Adv Anat Pathol. 2013;20(6):424–39.

    Article  CAS  PubMed  Google Scholar 

  22. Owen-Casey MP, Sim R, Cook HT, Roufosse CA, Gillmore JD, Gilbertson JA, Hutchison CA, Howie AJ. Value of antibodies to free light chains in immunoperoxidase studies of renal biopsies. J Clin Pathol. 2014;67:661–6.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Sethi S, Theis JD, Leung N, Dispenzieri A, Nasr SH, Fidler ME, Cornell LD, Gamez JD, Vrana JA, Dogan A. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol. 2010;5(12):2180–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Nasr SH, Said SM, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Dispenzieri A, Buadi FK, Vrana JA, Theis JD, Dogan A, Leung N. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int. 2013;83(3):463–70. Epub 2013 Jan 9.

    Article  CAS  PubMed  Google Scholar 

  25. Picken MM. Non-light-chain immunoglobulin amyloidosis: time to expand or refine the spectrum to include light + heavy chain amyloidosis? Kidney Int. 2013;83(3):353–6.

    Article  CAS  PubMed  Google Scholar 

  26. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21(4):221–4. 2014 Sep 29.

    Article  PubMed  Google Scholar 

  27. Mölne J, Breimer ME, Svalander CT. Immunoperoxidase versus immunofluorescence in the assessment of human renal biopsies. Am J Kidney Dis. 2005;45(4):674–83.

    Article  PubMed  Google Scholar 

  28. Furness PN. Acp. Best practice no 160. Renal biopsy specimens. J Clin Pathol. 2000;53(6):433–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Nasr SH, Galgano SJ, Markowitz GS, Stokes MB, D’Agati VD. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70(12):2148–51.

    CAS  PubMed  Google Scholar 

  30. Larsen C. Leukocyte chemotactic factor 2 amyloidosis can be reliably diagnosed by immunohistochemical staining. Hum Pathol. 2014;45(10):2179. Epub 2014 Jul 16.

    Article  CAS  PubMed  Google Scholar 

  31. Novak L, Cook WJ, Herrera GA, Sanders PW. AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant. 2004;19(12):3050–3.

    Article  PubMed  Google Scholar 

  32. Satoskar AA, Burdge K, Cowden DJ, Nadasdy GM, Hebert LA, Nadasdy T. Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med. 2007;131(6):917–22.

    PubMed  Google Scholar 

  33. Picken MM, Herrera GA. The burden of “sticky” amyloid: typing challenges. Arch Pathol Lab Med. 2007;131(6):850–1.

    PubMed  Google Scholar 

  34. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gillbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002;346(23):1786–91.

    Article  CAS  PubMed  Google Scholar 

  35. Comenzo RL, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood. 2006;107(9):3489–91. Epub 2006 Jan 26.

    Article  CAS  PubMed  Google Scholar 

  36. Picken MM, Hazenberg BPC, Obici L. Report from the diagnostic interactive session. In: Skinner M, Berk JL, Connors LH, Seldin DC, editors. XIth International Symposium on Amyloidosis; Boca Raton, FL: CRC Press; 2007. p. 377–82.

    Google Scholar 

  37. Rowczenio D, Dogan A, Theis JD, Vrana JA, Lachmann HJ, Wechalekar AD, Gilbertson JA, Hunt T, Gibbs SD, Sattianayagam PT, Pinney JH, Hawkins PN, Gillmore JD. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol. 2011;179(4):1978–87. Epub 2011 Aug 5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Loyola University Medical Center, Loyola University Chicago, Building 110, Room 2242, 2160 South First Avenue, Maywood, IL, 60153, USA

    Maria M. Picken MD, PhD

Authors
  1. Maria M. Picken MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria M. Picken MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA

    Maria M. Picken

  2. Department of Pathology, LSU Health Shreveport, Shreveport, Louisiana, USA

    Guillermo A. Herrera

  3. Department of Pathology and Laboratory Medicine, Department of Pathology and Laboratory Medicine, New York, New York, USA

    Ahmet Dogan

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Picken, M.M. (2015). Options for Amyloid Typing in Renal Pathology: The Advantages of Frozen Section Immunofluorescence and a Summary of General Recommendations Regarding Immunohistochemistry Methods. In: Picken, M., Herrera, G., Dogan, A. (eds) Amyloid and Related Disorders. Current Clinical Pathology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-19294-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19294-9_20

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-19293-2

  • Online ISBN: 978-3-319-19294-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation